Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure With Reduced Ejection Fraction

NCT03425422 is registered in ClinicalTrials.gov with LivaNova as lead sponsor.

NCT NCT03425422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03425422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure With Reduced Ejection Fraction
Lead sponsor
LivaNova
Phase
Not applicable
Overall status
Terminated
Start date
May 1, 2018
Completion date
May 31, 2023
Enrollment
533 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, heart failure, congestive, heart failure, systolic